MRI demonstration of gadolinium deposition in bone after monthly triple-dose gadopentetate dimeglumine and correlation with frequency of hypophosphatemia.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical imaging"
DOI: 10.1016/j.clinimag.2020.07.022
Abstract: OBJECTIVES We retrospectively analyzed data of the BECOME trial to investigate whether serial administration of triple-dose (3-dose) gadopentetate dimeglumine would result in the development of T1 signal-to-noise (S/N) changes in the cranial diploic space and… read more here.
Keywords: gadopentetate dimeglumine; dose gadopentetate; triple dose; bone ... See more keywords